Excessive blood loss in the prehospital setting poses a significant challenge and is one of the leading causes of death in the United States. In response, emergency medical services (EMS) have increasingly adopted the use of tranexamic acid (TXA) and calcium chloride (CaCl 2 ) as therapeutic interventions for hemorrhagic traumas. Tranexamic acid functions by inhibiting plasmin formation and restoring hemostatic balance, while calcium plays a pivotal role in the coagulation cascade, facilitating the conversion of factor X to factor Xa and prothrombin to thrombin. Despite the growing utilization of TXA and CaCl 2 in both prehospital and hospital environments, a lack of literature exists regarding the comparative effectiveness of these agents in reducing hemorrhage and improving patient outcomes. Notably, Morgan County Indiana EMS recently integrated the administration of TXA with CaCl 2 into their treatment protocols, offering a valuable opportunity to gather insight and formulate updated guidelines based on patient-centered outcomes. This narrative review aims to comprehensively evaluate the existing evidence concerning the administration of TXA and CaCl 2 in the prehospital management of hemorrhages, while also incorporating and analyzing data derived from the co-administration of these medications within the practices of Morgan County EMS. This represents the inaugural description of the concurrent use of both TXA and CaCl 2 to manage hemorrhages in the scientific literature.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510828PMC
http://dx.doi.org/10.1097/SHK.0000000000002177DOI Listing

Publication Analysis

Top Keywords

txa cacl
16
tranexamic acid
12
calcium chloride
8
prehospital setting
8
narrative review
8
cacl prehospital
8
morgan county
8
administration txa
8
txa
5
cacl
5

Similar Publications

Excessive blood loss in the prehospital setting poses a significant challenge and is one of the leading causes of death in the United States. In response, emergency medical services (EMS) have increasingly adopted the use of tranexamic acid (TXA) and calcium chloride (CaCl 2 ) as therapeutic interventions for hemorrhagic traumas. Tranexamic acid functions by inhibiting plasmin formation and restoring hemostatic balance, while calcium plays a pivotal role in the coagulation cascade, facilitating the conversion of factor X to factor Xa and prothrombin to thrombin.

View Article and Find Full Text PDF

Noncompressible hemorrhage is a major cause of posttrauma death and occupies the leading position among potentially preventable trauma-associated deaths. Recently, multiple studies have shown that strongly adhesive materials can serve as hemostatic materials for noncompressible hemorrhage. However, the risk of severe tissue adhesion limits the use of adhesive hydrogels as hemostatic materials.

View Article and Find Full Text PDF

Adsorption of Ba and Sr on TiCT MXene in model fracking wastewater.

J Environ Manage

February 2020

Department of Civil and Environmental Engineering, University of South Carolina, Columbia, 300 Main Street, SC, 29208, USA. Electronic address:

Wastewater from hydraulic fracking contains both organic and inorganic pollutants; the latter include radioactive nuclides such as Ba and Sr. We explored whether MXene (TiCT), a novel adsorbent, could remove Ba and Sr from model wastewater. Zeta potential analysis showed that MXene had a high negative surface charge.

View Article and Find Full Text PDF

The enhancement of TXA receptors-mediated contractile response in intrarenal artery dysfunction in type 2 diabetic mice.

Eur J Pharmacol

June 2017

Guangdong Cardiovascular Institute, PR China; Department of Medical Research, Guangdong General Hospital, PR China; Guangdong Academy of Medical Sciences, Guangzhou 510080, PR China. Electronic address:

Thromboxane A (TXA) has been implicated in the pathogenesis of diabetic vascular complications, although the underlying mechanism remains unclear. The present study investigated the alterations in TXA receptor signal transduction in type 2 diabetic renal arteries. The contraction of renal arterial rings in control (db/m+) mice and type 2 diabetic (db/db) mice was measured by a Multi Myograph System.

View Article and Find Full Text PDF

Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner.

J Atheroscler Thromb

September 2012

Department of Biomedical Laboratory Science, College of Biomedical Science and Engineering and Regional Research Center, Inje University, Gyungnam, Korea.

Aim: In this study, we investigated the effect of (-)-epigallocatechin-3-gallate (EGCG) on cyclic nucleotide production and vasodilator-stimulated phosphoprotein (VASP) phosphorylation in collagen (10 µg/mL)-stimulated platelet aggregation.

Methods: Washed platelets (10(8)/mL) from Sprague-Dawley rats (6-7 weeks old, male) were preincubated for 3 min at 37°C in the presence of 2 mM exogenous CaCl(2) with or without EGCG or other materials, stimulated with collagen (10 µg/mL) for 5 min, and then used for the determination of intracellular cytosolic Ca(2+) ([Ca(2+)](i)), thromboxane A(2) (TXA(2)), adenosine 3',5'-cyclic monophosphate (cAMP), guanosine 3',5'-cyclic monophosphate (cGMP), and VASP phosphorylation.

Results: EGCG dose-dependently inhibited collagen-induced platelet aggregation by inhibiting both [Ca(2+)](i) mobilization and TXA(2) production.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!